DUBLIN, Aug. 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the Global Regenerative Medicine (Stem Cell Therapy, Biomaterial and Tissue Engineering) Market (Bone and Joint) - Forecast to 2019" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Moreover, it has included stem cell therapy, tissue engineering and biomaterial under the umbrella of regenerative medicine. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. The global market for regenerative medicine bone and joint application is dominated by various bone graft substitute in 2012. However, it is expected that tissue engineering will become a lucrative market in future. Factors such as growing geriatric population, favorable government support and increasing bone and joint reconstructive surgeries accentuate growth of the global regenerative medicine bone and joint application market.
This research report explains various advancements occurring in this market and analyzes the global regenerative medicine (bone and joint) market by technology and application. The regenerative medicine bone and joint application market by technology is further segmented into stem cell therapy, biomaterials and tissue engineering. Likewise, on basis of application the global regenerative medicine (bone and joint) market is segmented as bone graft substitutes, osteoarticular diseases, allogenic bones, autogenic bone and others.
This report includes estimation of the global regenerative medicine (bone and joint) market in terms of value (USD million) for the period 2011 to 2019, considering 2012 as the base year. In addition, current trends and recent developments are taken into consideration while determining the growth rate of the global regenerative medicine (bone and joint) market. The report provides market size and forecast for each segment, sub-segment and geographic region with CAGR % for the period 2013 to 2019.
Geographically, the global regenerative medicine (bone and joint) market has been segmented into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). Market size, forecast and CAGR (%) for each region have been provided. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the regenerative medicine (bone and joint) market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has also been discussed in the study that is expected to help in decision-making.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Regenerative Medicine (Bone and Joint) Market, by Technology
Chapter 5 Regenerative Medicine (Bone and Joint) Market, by Applications
Chapter 6 Regenerative Medicine (Bone and Joint) Market, by Geography
Chapter 7 Recommendations
Chapter 8 Company Profiles
Companies Mentioned:
- Anika Therapeutics, Inc.
- Arthrex, Inc.
- Baxter International, Inc.
- CONMED Corporation
- DePuy Synthes, Inc.
- Medtronic, Inc.
- Smith & Nephew plc
- Stryker Corporation
- Zimmer Holdings, Inc.
For more information visit http://www.researchandmarkets.com/research/lbzf6w/regenerative
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
